Trademarkia Logo

Canada

C$
SAIL
FORMALIZED

on 2 Jan 2025

Last Applicant/ Owned by

Sail Biomedicines, Inc.

101 South St., Suite 400Somerville MA 02143

US

Serial Number

2372092 filed on 4th Jun 2024

Correspondent Address

MOFFAT & CO.

P.O. Box 2088, Station DOttawa

ONTARIO

CA

K1P5W3

SAIL

Trademark usage description

pharmaceutical preparations for use in gene therapy; biological and pharmaceutical preparations, both comprised of therapeutic nucleic acids, namely r Read More

Classification Information


Class [005]
Pharmaceutical preparations for use in gene therapy; biological and pharmaceutical preparations, both comprised of therapeutic nucleic acids, namely RNA, for the treatment and prevention of genetic diseases and disorders, genomic diseases and disorders, cancer, infectious diseases, and immune system related diseases and disorders; Therapeutic preparations to modulate metabolism; pharmaceutical preparations and agents to modulate metabolism; therapeutic pharmaceuticals for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; pharmaceutical preparations for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; therapeutic pharmaceuticals for modulating metabolism.


Classification kind code

12

Class [042]
Testing, inspection, research, and development of pharmaceutical preparations for gene therapy; research and development in the field of computational biology, biotechnology and pharmaceuticals.


Classification kind code

12

Mark Details


Serial Number

2372092

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 48
on 14th Feb 2025
Agent Changed
Submitted for opposition 257
on 2th Jan 2025
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 2th Jan 2025
Created
Submitted for opposition 31
on 2th Jan 2025
Formalized
Submitted for opposition 228
on 4th Jun 2024
International Registration
Submitted for opposition 30
on 4th Jun 2024
Filed